Anshul Specialty Molecules Limit Ed Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 2.37 Cr
as on 17-07-2024
- Company Age 53 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 57.27 Cr
as on 17-07-2024
- Satisfied Charges ₹ 3.49 Cr
as on 17-07-2024
- Revenue -8.89%
(FY 2023)
- Profit -48.97%
(FY 2023)
- Ebitda -81.60%
(FY 2023)
- Net Worth 4.63%
(FY 2023)
- Total Assets 8.02%
(FY 2023)
About Anshul Specialty Molecules Limit Ed
The Corporate was formerly known as Anshul Specialty Molecules Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.37 Cr.
The company currently has active open charges totaling ₹57.27 Cr. The company has closed loans amounting to ₹3.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwin Shroff, Ravi Shroff, Vipin Doshi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100MH1971PTC015364
- Company No.
015364
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 1971
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Anshul Specialty Molecules Limit Ed?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Doshi  | Director | 30-Aug-1984 | Current |
| Ashwin Shroff | Director | 14-Nov-2014 | Current |
| Ravi Shroff | Director | 20-Apr-2008 | Current |
| Shirish Satpute | Whole-Time Director | 01-Apr-2022 | Current |
| Ashok Isharani | Director | 23-Apr-2002 | Current |
| Jagdish Naik | Director | 21-Jul-2006 | Current |
Financial Performance and Corporate Structure Insights of Anshul Specialty Molecules Limit Ed.
Anshul Specialty Molecules Private Limit Ed, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.89% decrease. The company also saw a substantial fall in profitability, with a 48.97% decrease in profit. The company's net worth moved up by a moderate rise of 4.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anshul Specialty Molecules Limit Ed?
In 2023, Anshul Specialty Molecules Limit Ed had a promoter holding of 100.00%. The company had 3 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indian Centre For Climate And Societal Impacts ResearchActive 16 years 4 monthsAshwin Shroff is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 16 Nov 2010 | ₹4.95 Cr | Open |
Bank Of India Creation Date: 08 Sep 2006 | ₹25.88 Cr | Open |
Bank Of India Creation Date: 19 Nov 2004 | ₹25.88 Cr | Open |
How Many Employees Work at Anshul Specialty Molecules Limit Ed?
Anshul Specialty Molecules Limit Ed has a workforce of 205 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anshul Specialty Molecules Limit Ed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anshul Specialty Molecules Limit Ed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
